Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 5 | 2022 | 20572 | 0.300 |
Why?
|
| Immunotherapy | 6 | 2023 | 4137 | 0.260 |
Why?
|
| Tumor Microenvironment | 5 | 2023 | 3100 | 0.250 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2022 | 172 | 0.200 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2023 | 288 | 0.190 |
Why?
|
| Melanoma | 3 | 2023 | 5260 | 0.190 |
Why?
|
| Immune Evasion | 2 | 2021 | 364 | 0.180 |
Why?
|
| Lysine | 1 | 2022 | 1042 | 0.170 |
Why?
|
| Clone Cells | 1 | 2020 | 1760 | 0.150 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2020 | 469 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2023 | 4266 | 0.140 |
Why?
|
| Receptors, Androgen | 1 | 2022 | 1061 | 0.140 |
Why?
|
| Data Mining | 1 | 2021 | 544 | 0.140 |
Why?
|
| Melanoma, Experimental | 1 | 2018 | 564 | 0.130 |
Why?
|
| Leukemia | 1 | 2023 | 1529 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 6676 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 1426 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1752 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 1884 | 0.110 |
Why?
|
| Indoles | 1 | 2020 | 1859 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2020 | 1932 | 0.100 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2020 | 1949 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2011 | 276 | 0.090 |
Why?
|
| Computational Biology | 1 | 2021 | 3568 | 0.090 |
Why?
|
| Cell Line, Tumor | 5 | 2023 | 16989 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 2745 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2022 | 8685 | 0.080 |
Why?
|
| Software | 1 | 2022 | 4367 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 3333 | 0.080 |
Why?
|
| Chromatin | 3 | 2023 | 2741 | 0.080 |
Why?
|
| Macrophages | 1 | 2021 | 5814 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 5988 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22929 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 4928 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5271 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9532 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 4750 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1056 | 0.060 |
Why?
|
| Models, Biological | 1 | 2020 | 9892 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5495 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2011 | 2834 | 0.060 |
Why?
|
| Animals | 8 | 2023 | 170894 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2021 | 30 | 0.060 |
Why?
|
| Ikaros Transcription Factor | 1 | 2022 | 225 | 0.050 |
Why?
|
| Genes, myc | 1 | 2022 | 406 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2011 | 2959 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 13754 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 10651 | 0.050 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2019 | 96 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2022 | 985 | 0.040 |
Why?
|
| Mice | 6 | 2023 | 81128 | 0.040 |
Why?
|
| Gene Library | 1 | 2021 | 1093 | 0.040 |
Why?
|
| Complementarity Determining Regions | 1 | 2019 | 160 | 0.040 |
Why?
|
| Chemotaxis | 1 | 2021 | 618 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2023 | 682 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 3451 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2022 | 1025 | 0.040 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2019 | 421 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 944 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2021 | 1900 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 18353 | 0.040 |
Why?
|
| Humans | 13 | 2023 | 717280 | 0.040 |
Why?
|
| Chemokines | 1 | 2021 | 960 | 0.040 |
Why?
|
| Serpins | 1 | 2018 | 266 | 0.040 |
Why?
|
| Workflow | 1 | 2021 | 817 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2022 | 997 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2019 | 655 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 2176 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2022 | 1800 | 0.030 |
Why?
|
| Prostate | 1 | 2022 | 1604 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2020 | 10802 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 1902 | 0.030 |
Why?
|
| Proteome | 1 | 2022 | 1776 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2023 | 12073 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 6564 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3697 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2022 | 3016 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2184 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 1902 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2031 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 4916 | 0.020 |
Why?
|
| Gene Expression | 1 | 2022 | 8013 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 371 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3698 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 4486 | 0.020 |
Why?
|
| Base Sequence | 1 | 2019 | 13317 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 13262 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3778 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 1744 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2022 | 11762 | 0.020 |
Why?
|
| Apoptosis | 1 | 2020 | 10119 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1671 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2011 | 3022 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 9597 | 0.010 |
Why?
|
| Stem Cells | 1 | 2011 | 3597 | 0.010 |
Why?
|
| Mutation | 1 | 2020 | 29491 | 0.010 |
Why?
|
| Male | 2 | 2022 | 351399 | 0.010 |
Why?
|
| Female | 2 | 2022 | 377934 | 0.010 |
Why?
|
Concepts
(98)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(60)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_